Can Indivior Pharmaceuticals, Inc. cover its short-term obligations?

Its current ratio is 0.86 — current liabilities exceed current assets.

Where does Indivior Pharmaceuticals, Inc. 's balance sheet data come from?

Every line is extracted from Indivior Pharmaceuticals, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Indivior Pharmaceuticals, Inc. INDV Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$195M-38.9%	$319M+0.9%	$316M—	——
Accounts receivable, net	$995M+296%	$251M-10.0%	$278.75M+1,227%	$21M—
Inventories	$32M-37.3%	$51M-60.9%	$130.5M+335%	$30M—
Total current assets	$652M-21.2%	$827M-34.2%	$1.26B—	——
Property and equipment, net	$144M+44.0%	$100M+19.0%	$84M—	——
Goodwill	$2M-66.7%	$6M-53.8%	$13M—	——
Total assets	$1.2B-8.7%	$1.32B-25.1%	$1.76B—	——
Accounts payable	$48M-23.8%	$63M-67.7%	$195M—	——
Current portion of long-term debt	$29M+61.1%	$18M+500%	$3M—	——
Total current liabilities	$914M-1.1%	$924M-27.9%	$1.28B—	——
Long-term debt	$290M-7.9%	$315M+32.9%	$237M—	——
Total liabilities	$1.3B-21.3%	$1.65B-14.9%	$1.94B—	——
Common stock	$62M0.0%	$62M-8.8%	$68M—	——
Retained earnings	-$243M+45.1%	-$443M-53.8%	-$288M—	——
Total stockholders' equity	-$98M+70.9%	-$337M-83.2%	-$184M-1,127%	-$15M-112%
Total liabilities and stockholders' equity	$1.2B-8.7%	$1.32B-25.1%	$1.76B—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Indivior Pharmaceuticals, Inc. cover its short-term obligations?: Its current ratio is 0.86 — current liabilities exceed current assets.
Where does Indivior Pharmaceuticals, Inc. 's balance sheet data come from?: Every line is extracted from Indivior Pharmaceuticals, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.